Cellares vs Hillgene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellares/hillgene

Category	Cellares	Hillgene
Listed site	cdmo	cdmo
Summary	Cellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.	Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing CMC Analytical Development Process Development Quality Control Testing CMC Regulatory Submission Support Technology Transfer	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Lentiviral Vector Manufacturing mRNA Manufacturing Quality Control Testing Regulatory Affairs CMC Regulatory Submission Support
Modalities	Cell Therapy	Cell Therapy mRNA Gene Therapy
Indications	Data not yet provided.	Oncology Immunology
Locations	Smart Factory, South San Francisco, CA, United States Smart Factory, Bridgewater, NJ, United States Smart Factory - Europe, Leiden, Netherlands Smart Factory - Asia, Kashiwa, Japan	Headquarters, Suzhou, Jiangsu, China R&D Center, Suzhou, Jiangsu, China GMP Facility, Belgium, Belgium
Certifications	Data not yet provided.	FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.